Loading…
Clinician practices, knowledge, and attitudes regarding primary human papillomavirus testing for cervical cancer screening: A mixed-methods study in Indiana
•3% of surveyed Indiana clinicians conduct primary HPV testing for eligible patients.•50% of clinicians are willing to adopt primary HPV screening as preferred method.•Clinician knowledge is a key predictor of willingness to adopt primary HPV testing.•Cervical cancer screening guideline changes and...
Saved in:
Published in: | Preventive medicine reports 2023-02, Vol.31, p.102070, Article 102070 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •3% of surveyed Indiana clinicians conduct primary HPV testing for eligible patients.•50% of clinicians are willing to adopt primary HPV screening as preferred method.•Clinician knowledge is a key predictor of willingness to adopt primary HPV testing.•Cervical cancer screening guideline changes and misalignment led to uncertainty.
Primary human papillomavirus (HPV) testing, in which a high-risk HPV test is administered without cytology, was first included in 2018 US cervical cancer screening guidelines. Subsequent guidelines endorsed primary HPV testing as the preferred method for cervical cancer screening following evidence of its clinical and economic benefits, although many sources still indicate it as an option along with cytology and HPV/Pap co-testing. Primary HPV testing could be key to improving the declining cervical cancer screening rates in the US; however its adoption has been slow as clinicians are hesitant to make the change. Indiana ranks in the top ten states for cervical cancer mortality, with marked race-ethnic disparities in cervical cancer screening and low HPV vaccination rates. To examine clinician practices, knowledge, and attitudes regarding primary HPV testing, in 2021 we conducted an online cross-sectional survey (n = 224) and in-depth interviews (n = 20) with Indiana clinicians practicing cervical cancer screening. Only 3 % reported using primary HPV testing for eligible patients, and only 50 % were willing to adopt it as the preferred cervical cancer screening method for the recommended patient group. In a multivariable logistic regression model, knowledge of the effectiveness (aOR 2.58 [1.41–4.72]) and perceived benefit (aOR 7.35 [3.65–14.81]) of primary HPV testing predicted willingness to adopt. In-depth interviews revealed knowledge gaps, uncertainty, and perceived limitations of this method as the reasons for limited uptake of primary HPV testing. Targeted messages about the benefits and effectiveness may enhance clinician knowledge, acceptance, and adoption. |
---|---|
ISSN: | 2211-3355 2211-3355 |
DOI: | 10.1016/j.pmedr.2022.102070 |